Anti-NLRP3-ACS antibody

N/A

Report date: 2022/04/18 10:14:18

Base Information

Drug NameAnti-NLRP3-ACS antibody
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitorsApoptosis-associated speck-like protein containing a CARD inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3Apoptosis-associated speck-like protein containing a CARD
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune Sa
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A